HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/1/G110    most recent 00148.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (21) Citing Articles via Google Scholar Google Scholar Articles by Storr, M. Articles by Allescher, H. D. Search for Related Content PubMed PubMed Citation Articles by Storr, M. Articles by Allescher, H. D.

NEUROREGULATION AND MOTILITY

Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon

¹GAP, Department of Internal Medicine II, Technical University of Munich, 81675 Munich; ²Group Molecular Genetics of Behaviour, Max-Planck-Institute of Psychiatry, 80804 Munich, Germany; and ³Laboratory of Cell Biology and Histology, Department of Biomedical Sciences, University of Antwerp, 2020 Antwerpen, Belgium

Submitted 31 March 2003 ; accepted in final form 28 July 2003

The effects of cannabinoid receptor agonists and antagonists on smooth muscle resting membrane potentials and on membrane potentials following electrical neuronal stimulation in a myenteric neuron/smooth muscle preparation of wild-type and cannabinoid receptor type 1 (CB1)-deficient mice were investigated in vitro. Double staining for CB1 and nitric oxide synthase (neuronal) was performed to identify the myenteric CB1-expressing neurons. Focal electrical stimulation of the myenteric plexus induced a fast (f) excitatory junction potential (EJP) followed by a fast and a slow (s) inhibitory junction potential (IJP). Treatment of wild-type mice with the endogenous CB1 receptor agonist anandamide reduced EJP while not affecting fIJP and sIJP. EJP was significantly higher in CB1-deficient mice than in wild-type littermate controls, and anandamide induced no effects in CB1-deficient mice. N-arachidonoyl ethanolamide (anandamide), R-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3,-de]- 1,4-benzoxazin-6-yl]-1-naphtalenylmethanone, a synthetic CB1 receptor agonist, nearly abolished EJP and significantly reduced the fIJP in wild-type mice. N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-caroxamide (SR141716A), a CB1-specific receptor antagonist, was able to reverse the agonist effects induced in wild-type mice. SR141716A, when given alone, significantly increased EJP in wild-type mice without affecting IJP in wild-type and EJP in CB1-deficient mice. Interestingly, SR141716A reduced fIJP in CB1-deficient mice. In the mouse colon, nitrergic myenteric neurons do not express CB1, implying that CB1 is expressed in cholinergic neurons, which is in line with the functional data. Finally, excitatory and inhibitory neurotransmission in the mouse colon is modulated by activation of CB1 receptors. The significant increase in EJP in CB1-deficient mice strongly suggests a physiological involvement of CB1 in excitatory cholinergic neurotransmission.

anandamide; cannabinoid receptor type 1-deficient mice; intracellular recording; excitatory junction potential; inhibitory junction potential; N-arachidonoyl ethanolamide (anandamide); R-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3,-de]-1; 4-benzoxazin-6-yl]-1-naphtalenylmethanone; N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-caroxamide

This article has been cited by other articles:

				A. Sibaev, B. Yuce, M. Kemmer, L. Van Nassauw, U. Broedl, H. D. Allescher, B. Goke, J.-P. Timmermans, and M. Storr Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon Am J Physiol Gastrointest Liver Physiol, January 1, 2009; 296(1): G119 - G128. [Abstract] [Full Text] [PDF]

				M. Duncan, A. D. Thomas, N. L. Cluny, A. Patel, K. D. Patel, B. Lutz, D. Piomelli, S. P. H. Alexander, and K. A. Sharkey Distribution and function of monoacylglycerol lipase in the gastrointestinal tract Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1255 - G1265. [Abstract] [Full Text] [PDF]

				A A Izzo and M Camilleri Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects Gut, August 1, 2008; 57(8): 1140 - 1155. [Abstract] [Full Text] [PDF]

				M. Duncan, A. Mouihate, K. Mackie, C. M. Keenan, N. E. Buckley, J. S. Davison, K. D. Patel, Q. J. Pittman, and K. A. Sharkey Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G78 - G87. [Abstract] [Full Text] [PDF]

				S. M Brierley, R Carter, W Jones III, L. Xu, D. R Robinson, G. A Hicks, G. F Gebhart, and L. A. Blackshaw Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice J. Physiol., August 15, 2005; 567(1): 267 - 281. [Abstract] [Full Text] [PDF]